Clinical Trial Update: Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating allogeneic mesenchymal stromal cells to promote angiogenesis and neovascularization in people with no-option isch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Peripheral Arterial Disease
• Vascular Diseases

Drugs mentioned

• Allogeneic Mesenchymal Stromal Cells (mesenchymal stromal cells)

Snippet

Sponsor: Martin Teraa, MD, PhD | Conditions: Peripheral Arterial Disease, Cardiovascular Diseases | Phase 2, Phase 3 | Status: UNKNOWN